首页>
外国专利>
METHODS AND COMPOSITIONS OF 32P-LABELED ADENINE NUCLEOTIDES FOR THE TREATMENT OF ATHEROSCLEROSIS, VASCULAR ARTERIAL DISEASES AND CORONARY ARTERY DISEASES
METHODS AND COMPOSITIONS OF 32P-LABELED ADENINE NUCLEOTIDES FOR THE TREATMENT OF ATHEROSCLEROSIS, VASCULAR ARTERIAL DISEASES AND CORONARY ARTERY DISEASES
展开▼
机译:[32P]标记的腺嘌呤核苷酸治疗动脉粥样硬化,血管性动脉疾病和冠状动脉疾病的方法和组成
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method for the treatment of atherosclerosis. The method includes the administration of a 32P-labeled agent as a beta emitter, such as 32P-labeled ATP or other 32P-labeled adenine nucleotides, whereby the 32P-labeled agent seeks and then permeates the atherosclerotic plaque en bloc without prior degradation. The accumulation of the 32P-labeled agent in the atherosclerotic plaque is achieved at time points whereby the 32P-labeled agent is cleared from the blood. Thus, radionuclide-labeled adenine nucleotides accumulate with high specificity in atherosclerotic lesions and in the heart. The beta particles (electrons) emitted by the 32P-label have a maximal path distance of about 0.5 cm and their energy preferentially destroy cells present in the atherosclerotic plaque without affecting vessel integrity or inducing arterial thrombosis.
展开▼